These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

827 related articles for article (PubMed ID: 18848685)

  • 1. Absence of recurrent stroke after percutaneous closure of patent foramen ovale despite residual right-to-left cardiac shunt assessed by transcranial Doppler.
    van de Wyngaert F; Kefer J; Hermans C; Ovaert C; Pasquet A; Beguin C; Sindic C; Sluysmans T
    Arch Cardiovasc Dis; 2008; 101(7-8):435-41. PubMed ID: 18848685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial Doppler quantification of residual shunt after percutaneous patent foramen ovale closure. Comparison of two devices.
    Sorensen SG; Aguilar H; McKnight WK; Thomas H; Muhlestein JB
    J Interv Cardiol; 2010 Dec; 23(6):575-80. PubMed ID: 20796165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
    Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
    Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual shunt after patent foramen ovale closure: preliminary results from Italian patent foramen ovale survey.
    Caputi L; Butera G; Anzola GP; Carminati M; Carriero MR; Chessa M; Onorato E; Rigatelli G; Sangiorgi G; Santoro G; Spadoni I; Ussia GP; Vigna C; Zanchetta M; Parati E;
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e219-26. PubMed ID: 23352683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of residual shunts after initial percutaneous patent foramen ovale closure: a single center experience with immediate and long-term follow-up.
    Diaz T; Cubeddu RJ; Rengifo-Moreno PA; Cruz-Gonzalez I; Solis-Martin J; Buonanno FS; Inglessis I; Palacios IF
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):145-50. PubMed ID: 20578100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study.
    Marchese N; Pacilli MA; Inchingolo V; Fanelli R; Loperfido F; Vigna C
    EuroIntervention; 2013 Jul; 9(3):382-8. PubMed ID: 23872652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permanent right-to-left shunt is the key factor in managing patent foramen ovale.
    Rigatelli G; Dell'Avvocata F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Mandapaka S; Kuruvilla J; Chen JP; Nanjundappa A
    J Am Coll Cardiol; 2011 Nov; 58(21):2257-61. PubMed ID: 22078434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcranial Doppler Screening for Patent Foramen Ovale Closure in Cryptogenic Strokes in Young: A Single Center Experience from South India.
    Bal D; Ahmed Shaikh AI; Rayani M; Aaron S; Thompson VS; Jose J; Krupa J; Benjamin RN; Rajkumar JL; Prabhakar AT
    J Assoc Physicians India; 2022 Oct; 70(10):11-12. PubMed ID: 37355867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent and Residual Shunts After Patent Foramen Ovale Closure: Results From a Long-Term Transcranial Doppler Study.
    Cheli M; Canepa M; Brunelli C; Bezante GP; Favorini S; Rollando D; Sivori G; Viani E; Finocchi C; Balbi M
    J Interv Cardiol; 2015 Dec; 28(6):600-8. PubMed ID: 26643006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): consideration for primary prevention closure?
    Rigatelli G; Dell'Avvocata F; Giordan M; Braggion G; Aggio S; Chinaglia M; Roncon L; Cardaioli P; Chen JP
    J Interv Cardiol; 2009 Aug; 22(4):398-403. PubMed ID: 19515082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent venous valves correlate with increased shunt and multiple preceding cryptogenic embolic events in patients with patent foramen ovale: an intracardiac echocardiographic study.
    Rigatelli G; Dell'avvocata F; Braggion G; Giordan M; Chinaglia M; Cardaioli P
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):973-6. PubMed ID: 19021284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcranial doppler quantification of residual shunt after percutaneous patent foramen ovale closure: efficacy of the GORE(®) HELEX septal occluder.
    Sorensen SG; Smout R; Spruance SL
    J Interv Cardiol; 2011 Aug; 24(4):366-72. PubMed ID: 21492220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of secondary source of right-to-left shunt with balloon occlusion of patent foramen ovale and power M-mode transcranial Doppler.
    Jesurum JT; Fuller CJ; Renz J; Krabill KA; Spencer MP; Reisman M
    JACC Cardiovasc Interv; 2009 Jun; 2(6):561-7. PubMed ID: 19539262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of residual shunt at 6 and 12 months after transoesophageal echocardiography-guided percutaneous closure of a patent foramen ovale for cryptogenic stroke.
    Witte LS; El Bouziani A; Beijk MAM; Robbers-Visser D; Coutinho JM; Tijssen JGP; Straver B; Bouma BJ; de Winter RJ
    Heart; 2024 Sep; 110(19):1172-1179. PubMed ID: 39122559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up of residual shunt after patent foramen ovale closure.
    Orzan F; Liboni W; Bonzano A; Molinari F; Ribezzo M; Rebaudengo N; Grippi G; Negri E
    Acta Neurol Scand; 2010 Oct; 122(4):257-61. PubMed ID: 19951266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt.
    Biasco L; Infantino V; Orzan F; Vicentini S; Rovera C; Longo G; Chinaglia A; Belli R; Allais G; Gaita F
    J Cardiol; 2014 Nov; 64(5):390-4. PubMed ID: 24713153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants and clinical significance of persistent residual shunting in patients with percutaneous patent foramen ovale closure devices.
    Shafi NA; McKay RG; Kiernan FJ; Silverman IE; Ahlquist M; Silverman DI
    Int J Cardiol; 2009 Nov; 137(3):314-6. PubMed ID: 19616327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of recurrent cryptogenic stroke with percutaneous closure of patent foramen ovale; one year follow-up study with magnetic resonance imaging and Holter monitoring.
    Ateş AH; Sunman H; Aytemir K; Yorgun H; Canpolat U; Topcuoğlu MA; Karlı Oğuz K; Şahiner L; Kaya EB; Tokgözoğlu L; Kabakçı G; Oto A
    Turk Kardiyol Dern Ars; 2015 Jan; 43(1):38-46. PubMed ID: 25655849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency of transcatheter patent foramen ovale closure in children after paradoxical embolism events.
    Wawrzyńczyk M; Gałeczka M; Karwot B; Knop M; Białkowski J
    Kardiol Pol; 2016; 74(4):385-9. PubMed ID: 26412471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.